Imugene Ltd showcases new PD1-Vaxx data at World Conference on Lung Cancer

Imugene Ltd (ASX:IMU, OTC:IUGNF) has presented findings from its PD1-Vaxx trial in non-small cell lung cancer patients at the International Association for...

Related Keywords

Vienna ,Wien ,Austria ,Leslie Chong ,Michael Boyer ,Imugene Ltd ,International Association ,Lung Cancer ,World Conference ,Professor Michael Boyer ,Vaxx Phase ,